Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127163181 | 12716318 | 1 | I | 20160829 | 20160906 | 20160906 | EXP | US-ROCHE-1823850 | ROCHE | HARRISON J, STELLA P, LAVASSEUR B, ADAMS P, SWAFFORD L, LEWIS J, MENDELSOHN-VICTOR K AND FRIESE C. TOXICITY-RELATED FACTORS ASSOCIATED WITH USE OF SERVICES AMONG COMMUNITY ONCOLOGY PATIENTS. JOURNAL OF ONCOLOGY PRACTICE 2016 AUG;12(8):E818-E827. | 0.00 | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127163181 | 12716318 | 1 | PS | Rituximab | RITUXIMAB | 1 | Unknown | U | 103705 | ||||||||||
| 127163181 | 12716318 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | ||||||||||
| 127163181 | 12716318 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | U | 0 | ||||||||||
| 127163181 | 12716318 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 | ||||||||||
| 127163181 | 12716318 | 5 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | U | 0 | ||||||||||
| 127163181 | 12716318 | 6 | SS | BENDAMUSTINE | BENDAMUSTINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127163181 | 12716318 | 1 | Neoplasm malignant |
| 127163181 | 12716318 | 2 | Neoplasm malignant |
| 127163181 | 12716318 | 3 | Neoplasm malignant |
| 127163181 | 12716318 | 4 | Neoplasm malignant |
| 127163181 | 12716318 | 5 | Neoplasm malignant |
| 127163181 | 12716318 | 6 | Neoplasm malignant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127163181 | 12716318 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127163181 | 12716318 | Chills | |
| 127163181 | 12716318 | Complication associated with device | |
| 127163181 | 12716318 | Constipation | |
| 127163181 | 12716318 | Dyspnoea | |
| 127163181 | 12716318 | Nausea | |
| 127163181 | 12716318 | Oedema | |
| 127163181 | 12716318 | Pain | |
| 127163181 | 12716318 | Pharyngeal ulceration | |
| 127163181 | 12716318 | Pyrexia | |
| 127163181 | 12716318 | Stomatitis | |
| 127163181 | 12716318 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |